New Findings
Scientists show drug may greatly improve cancer immunotherapy success
A study led by the University of Southampton, funded by Cancer Research UK, has shown a new drug – originally developed to…
Potential Breakthrough in the Search for New Treatment Options for Esophageal Cancer Patients
Kishore Guda, DVM, PhD, an associate professor of oncology at Case Western Reserve University School of Medicine, has been awarded $200,000 by…
This may change medicine forever
How AI and machine intelligence are impacting doctors’ diagnoses. https://www.verizon.com/about/our-company/fourth-industrial-revolution/may-change-medicine-forever…
Ingestible medical devices can be broken down with light
A variety of medical devices can be inserted into the gastrointestinal tract to treat, diagnose, or monitor GI disorders. Many of these…
Toshiba develops way to accurately detect cancers from drop of blood
This photo shows a device developed by Toshiba Corp. that can detect 13 types of cancer from a single drop of blood…
Toshiba develops way to accurately detect cancers from drop of blood
This photo shows a device developed by Toshiba Corp. that can detect 13 types of cancer from a single drop of blood…
Common Symptoms that people avoided but can lead to a bigger problem
Following is a list of some common symptoms most of us experience day in and day out. Here is why you should…
SU2C-supported trials seek to extend CAR T-cell therapy to solid tumors
Stand Up To Cancer is helping scientists make progress in one of the most important areas of cancer research today: expanding the…
‘Wearable’ device captures cancer cells from blood
Research shows that most cancer cells can not survive in the bloodstream, but those that do are more likely to start a…
FDA grants fast track designation to tumor-detecting intraoperative imaging agent
The FDA granted fast track designation to ONM-100, an IV intraoperative imaging agent used to detect tumors and metastatic lymph nodes during…
Innovent, Lilly Co-developed Tyvyt Gets China’s NMPA Approval For CHL
China-based Innovent Biologics, Inc. and Eli Lilly and Co. ( LLY ) announced Friday that their co-developed Tyvyt, a fully human anti-PD-1…
Innovent, Lilly Co-developed Tyvyt Gets China's NMPA Approval For CHL
China-based Innovent Biologics, Inc. and Eli Lilly and Co. ( LLY ) announced Friday that their co-developed Tyvyt, a fully human anti-PD-1…